These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10188756)

  • 41. Corticosteroids in sepsis: a new concept for an old drug.
    Klaitman V; Almog Y
    Isr Med Assoc J; 2003 Jan; 5(1):51-5. PubMed ID: 12592960
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment.
    Zeni F; Freeman B; Natanson C
    Crit Care Med; 1997 Jul; 25(7):1095-100. PubMed ID: 9233726
    [No Abstract]   [Full Text] [Related]  

  • 43. Sepsis and septic shock.
    Zanetti G; Baumgartner JD; Glauser MP
    Schweiz Med Wochenschr; 1997 Mar; 127(12):489-99. PubMed ID: 9106949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Sepsis in the critically-ill patient].
    Christensen VB; Nielsen JS; Tønnesen EK
    Ugeskr Laeger; 2007 Feb; 169(8):703-5. PubMed ID: 17313921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current advances in sepsis and septic shock with particular emphasis on the role of insulin.
    Das UN
    Med Sci Monit; 2003 Aug; 9(8):RA181-92. PubMed ID: 12942044
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of septic shock with antibodies to tumour necrosis factor.
    Cohen J; Exley AR
    Schweiz Med Wochenschr; 1993 Mar; 123(11):492-6. PubMed ID: 8475356
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic and organ dysfunction response during infusion of recombinant human activated protein C (rhAPC) in severe sepsis and septic shock.
    Gullo A; Iscra F; Di Capua G; Berlot G; Lucangelo U; Peratoner A; Fasiolo S; Viviani M; Consales C; Zicari A
    Minerva Anestesiol; 2005 Dec; 71(12):785-801. PubMed ID: 16288186
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Septic shock: new pharmacotherapy options or better trial design?
    Vincent JL; Van Nuffelen M
    Expert Opin Pharmacother; 2013 Apr; 14(5):561-70. PubMed ID: 23452102
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of Hydrocortisone on Regulating Inflammation, Hemodynamic Stability, and Preventing Shock in Severe Sepsis Patients.
    Zhao Y; Ding C
    Med Sci Monit; 2018 May; 24():3612-3619. PubMed ID: 29845974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological utility of melatonin in the treatment of septic shock: experimental and clinical evidence.
    Escames G; Acuña-Castroviejo D; López LC; Tan DX; Maldonado MD; Sánchez-Hidalgo M; León J; Reiter RJ
    J Pharm Pharmacol; 2006 Sep; 58(9):1153-65. PubMed ID: 16945173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antithrombin: prospects in clinical practice. Sespsi: anticoagulant or anti-inflammatory agents?].
    Imberti D
    Minerva Anestesiol; 2003 May; 69(5):371-5. PubMed ID: 12768169
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Severe sepsis and septic shock].
    Tønnesen E; Larsen K
    Ugeskr Laeger; 2014 Jul; 176(28):V03130200. PubMed ID: 25292001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does Early and Appropriate Antibiotic Administration Improve Mortality in Emergency Department Patients with Severe Sepsis or Septic Shock?
    Sherwin R; Winters ME; Vilke GM; Wardi G
    J Emerg Med; 2017 Oct; 53(4):588-595. PubMed ID: 28916120
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-inflammatory effects of benzenediamine derivate FC-98 on sepsis injury in mice via suppression of JNK, NF-κB and IRF3 signaling pathways.
    Song Y; Liu X; Yue H; Ji J; Dou H; Hou Y
    Mol Immunol; 2015 Oct; 67(2 Pt B):183-92. PubMed ID: 26032013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pathophysiology of sepsis and possible influence of statins].
    Fraunberger P; Drexel H; Walli AK
    Dtsch Med Wochenschr; 2010 Oct; 135(43):2128-32. PubMed ID: 20960384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunomodulatory therapies for sepsis: unexpected effects with macrolides.
    Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S39-43. PubMed ID: 18707849
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Optimum treatment of severe sepsis and septic shock: evidence in support of the recommendations.
    Balk RA
    Dis Mon; 2004 Apr; 50(4):168-213. PubMed ID: 15133467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increasing the efficacy of anti-inflammatory agents used in the treatment of sepsis.
    Minneci P; Deans K; Natanson C; Eichacker PQ
    Eur J Clin Microbiol Infect Dis; 2003 Jan; 22(1):1-9. PubMed ID: 12582737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Therapeutic options to improve the microcirculation in sepsis and septic shock].
    Ragaller M; Theilen H; Koch T
    Hamostaseologie; 2007 Feb; 27(1):59-63. PubMed ID: 17279278
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program.
    Ferrer R; Martin-Loeches I; Phillips G; Osborn TM; Townsend S; Dellinger RP; Artigas A; Schorr C; Levy MM
    Crit Care Med; 2014 Aug; 42(8):1749-55. PubMed ID: 24717459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.